Navigation Links
A Just Published Book Promises To Guide Women Regarding Their Frequent UTI’

Dr. Elizabeth Kavaler has claimed that her new book that has just been realised would help women in understanding and identifying their urinary tract disorder. //

The author, who is also a practising urologist, has said that many women are usually frequent visitors to the public toilet in their community, while many plan their outing with necessary visits to the toilets. She is of the opinion that many of the conditions that cause the women to suffer might be easily identified and treated very easily.

Others suffer recurrent urinary infections. In the course of a lifetime, more than half of all women will experience some form of debilitating urinary tract disease or discomfort, including infections, incontinence, pelvic floor prolapse, and interstitial cystitis. Until recently, there has been only scant attention paid to this very common group of disorders.

A Seat on the Aisle, Please! will help women identify and understand urinary tract disorders and play a more informed and active role in seeking help from their physicians. In her years as a practicing urologist, Dr. Elizabeth Kavaler has come to believe that women of all ages suffer needlessly, and for far too long, from many kinds of pelvic disorders and urinary tract discomforts that can be treated and relieved. In the Introduction she writes, "My book touches on disorders that affect millions of women, most of who have no idea were to turn for help. I am aware of the difficulties that women face when they are seen by male urologists, who traditionally treat male problems."

In this concise, clearly written, and sympathetic new book, Kavaler suggests that a new approach to urinary tract disorders is long overdue. One of the surprisingly small number of women practicing urology in the U.S., she explains what these diseases are and what patients can do to get themselves diagnosed and treated properly. But more than that, Dr. Kavaler extends expert, sympathetic, and helpful a
'"/>




Page: 1 2

Related medicine news :

1. Findings on Dangerous Parasite, Toxoplasma Gondii Published
2. Siddha Medicine Texts to Be Published in English
3. Marijuana-Derived Drug Promises Hope In Treating Bladder Infection
4. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
5. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
6. Maternal Vitamin D Supplementation Promises Healthy Bones In Child
7. Raw Vegan Diet Promises Lightweight, Healthy Bones
8. Stem Cell Transplantation Promises Cure for Type 2 Diabetes
9. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
10. Health Minister Promises Strict Quality Control On Herbal Medicines
11. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
Post Your Comments:
(Date:12/2/2008)...tCall/ -- Quest Diagnostics Incorporated (NYSE: ...testing, information and services, announced that ...thcare Conference in New York City today, December...cheduled to begin at 4:00 p.m. Eastern Time. , ...affirm its 2008 guidance for revenue growth of gre...
(Date:12/2/2008)...er with aprotinin, a drug commonly used to control...y, compared with lysine analogues, according to a ...9 to be published in the January 20th issue of C...dvisory panel will meet to decide on aprotinin use...the meeting. , The study, a systematic review o...
(Date:12/2/2008)...rstCall/ - NUCRYST Pharmaceuticals Corp., a develo...t infection and inflammation, announced today that...rity shareholder, The Westaim Corporation ("Westai...areholders to consider a return of capital of US$0...s to a return of capital of approximately US$15 mi...
(Date:12/2/2008)...e Efficacy of Commercially Available Hypomethylati... Eisai Corporation of North Americ...rst clinical trial evaluating the activity of Daco...za(R) (azacitidine) in adult patients with interme...ic syndromes (MDS), a potentially life-threatening...
Breaking Medicine News(10 mins):Health News:Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 3Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3
... the researchers at the McMaster University includ...till remains controversial.// Sports drink play a...s carbohydrates and sodium. Carbohydrates provide ...ntains fluid balance in the body. The study, which...
...ave discovered that fibrin fibers could stretch to...riginal state, while some could even stretch to si...Fibrin involved in blood clotting is developed in ...inogen. When an injury occurs fibrin is deposited...
...iday banned the sale and consumption of soft drink...e have imposed a ban on soft drinks in all educati...an Education Minister Ghanshyam Tiwari told IANS h...o 100,000 government and private institutes where ...
... popular supermarket chains have announced that th...in their products.// Trans fat was recently in th...rt diseases. It is also thought to cause cancers a... are Sainsbury, Asda and Tesco. It was found that ...
Other Medicine News:Health News:Is Addition Of Proteins In The Sports Drink Beneficial? 2
(Date:12/1/2008)...e Call Scheduled for Tuesday, December 9 at 11:00 ..., , SOUTH SAN FRANCISCO, Calif., Dec. 1 /...Inc. (Nasdaq: SNSS ), a biopharmaceutical compan... of new oncology therapeutics, today announced new...id leukemia (AML) will be presented during the 50t...
(Date:11/28/2008)..., Germany, November 28 German biot...ship in specialized HIV monitoring and,AIDS patie...ng countries. In,the year 2008, 2.5 million patie...obust and highly affordable "CyFlow" system, suppo...ith HIV/AIDS. Due to introduction of the,Partec i...
(Date:11/26/2008)...ed to 406 Subjects , , FRANKLIN, Mass., Nov...TC Bulletin Board: PLCSF) announced today that it ...Drug Administration (FDA) for its U.S. pivotal tri...alGuard System(TM) and associated therapy in the ..., , The FDA also approved PLC,s request to ...
(Date:11/25/2008)...ANCISCO, Calif., Nov. 25 ... a biopharmaceutical company focused on,innovativ... be exploring,strategic alternatives for its prec...ompany to focus its resources on the clinical deve..., and to support the initial commercialization of,...
Breaking Medicine Technology:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3STERIS Corporation Announces New 24300 Million Share Repurchase Authorization 14383 1STERIS Corporation Announces New 24300 Million Share Repurchase Authorization 14383 2STERIS Corporation Announces New 24300 Million Share Repurchase Authorization 14383 3SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA Rich Safflower Oil 3970 1SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA Rich Safflower Oil 3970 2SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA Rich Safflower Oil 3970 3The ABCs of childhood zs 3A Snoring may be chronic despite surgery 14382 1The ABCs of childhood zs 3A Snoring may be chronic despite surgery 14382 2Low exposure to asbestos like mineral from Montana vermiculite may up lung disease risk 2504 1Low exposure to asbestos like mineral from Montana vermiculite may up lung disease risk 2504 2
...ll/ - Research,collaborators with Oncolytics Biote...poster presentation covering REOLYSIN(R),clinical ...ology,(ASCO) Annual Meeting, to be held June 1-5, ...ncolytics, U.K. Phase I systemic,administration tr...ase I Study of,Wild-Type Oncolytic Reovirus Admini...
...007 - A therapeutic,vaccine developed by the Germa...ew hope for cancer patients. The results of a,succ...d to an,international audience at the Annual Confe...y (ASCO) in Chicago, USA. ASCO is the,most importa...,world-wide., The active substance VPM4001, an imm...
Other Medicine Technology:Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2Vakzine Projekt Management Reports Positive Clinical Trial Results,With Their Therapeutic Prostate Cancer Vaccine VPM4001 2
...e BP monitor is designed to automatically measure ...BP along with heart rate. It's a Blood Pressure mo...ergometer and pharmacological stress test environm...ronments., ,Tango excels where other BP monit...
BD Visiswab Cotton Swab
...l, Philips Zymed 1810 Series offers retrospective ... the operator the flexibility to adjust the algori...application beyond the basic 1810 and you have eve...matic style that best meets the challenges of each...
...s STG for PC captures, displays, replays and analy...be effective in evaluating heart illnesses, pneumo...ase.,It provides objective evidence as a complem...time-expanded waveform displays, Phonocardiogra...
Medicine Products: